Achetez Aubrai by Bio (AUBRAI) en Japan

Aubrai by Bio is a decentralized science project launched on the Base network, representing a collaboration between Bio Protocol and VitaDAO. The project introduces what is described as the first decentralized AI agent focused on longevity science, known as a BioAgent. This AI agent, named Aubrai, is designed to function as an on-chain co-scientist that assists in accelerating research aimed at combating biological aging. The project is built on a foundation of scientific knowledge derived from thousands of private lab notes, internal communications, and unpublished insights from the laboratory of Dr. Aubrey de Grey, a prominent figure in longevity research. By integrating this specialized data with the collective intelligence of the global longevity community, the agent can generate and validate scientific hypotheses, design wet-lab experiments, and securely encrypt research data to protect intellectual property while maintaining transparency on the blockchain. A central part of the project's mission involves the Robust Mouse Rejuvenation study, which seeks to demonstrate the effectiveness of multi-target rejuvenation treatments. The Aubrai agent has been utilized to analyze this study, suggesting methodological improvements and identifying potential issues that might otherwise take researchers weeks to find manually. The AUBRAI token serves several key functions within this ecosystem. It is a utility and governance token that allows participants to influence the project's direction and research priorities. Token holders can vote on funding allocations for specific experiments and participate in the governance of the agent's research outputs. Furthermore, the project utilizes a model where scientific discoveries can be tokenized into intellectual property tokens. This system is designed to create a sustainable funding cycle where revenue from commercialized inventions can be shared with contributors and researchers, bypassing traditional funding gaps often found in scientific development. Technologically, the project leverages the BioAgents framework and tools like ElizaOS to create an autonomous environment where AI can manage research workflows and interact with decentralized finance protocols. This approach aims to move biotechnology from the hypothesis stage to commercial application more quickly by using blockchain to ensure data integrity and facilitate global coordination among researchers and patients. Overall, Aubrai by Bio represents a significant step in the decentralized science movement, combining artificial intelligence with blockchain technology to democratize access to life extension research and development. En savoir plus